Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro

Reproductive Toxicology

Volumn 30, Issue 3, 2010, Pages 370-376

  Helmestam, Malin ^a   Stavreus Evers, Anneli ^a   Olovsson, Matts ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Cadmium chloride; Co culture; Endocrine disruptor; Endometrium; Human endometrial endothelial cells; In vitro; QPCR

Indexed keywords

CADMIUM CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CASE REPORT; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIAL DISEASE; ENDOMETRIUM CELL; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RISK FACTOR; STROMA CELL;

CADMIUM CHLORIDE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENDOMETRIUM; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; PREGNANCY PROTEINS; RNA, MESSENGER; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956458756     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.05.003     Document Type: Article

References (52)

1. IARC, 1993. Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. IARCMonographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, vol. 58. Lyon, France:International Agency for Research on Cancer. 444 pp.
2. Thompson J., Bannigan J. Cadmium: toxic effects on the reproductive system and the embryo. Reprod Toxicol 2008, 25:304-315.
3. Järup L., Åkesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009, 238:201-208.
4. Shiverick K.T., Salafia C. Cigarette smoking and pregnancy. I. Ovarian, uterine and placental effects. Placenta 1999, 20:265-272.
5. Nordberg M. Environmental exposure and preventive measures in Sweden and EU BioMetals 2004, 17:589-592.
6. Henson M.C., Chedrese P.J. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med (Maywood) 2004, 229:383-392.
7. Iavicoli I., Fontana L., Bergamaschi A. The effects of metals as endocrine disruptors. J Environ Sci Health B 2009, 12:206-223.
8. Garcia-Morales P., Saceda M., Kenney N., Kim N., Salomon D.S., Gottardis M.M., et al. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 1994, 269:16896-16901.
9. Lienesch L.A., Dumont J.N., Bantle J.A. The effect of cadmium on oogenesis in Xenopus laevis. Chemosphere 2000, 41:1651-1658.
10. Rehm S., Waalkes M.P. Cadmium-induced ovarian toxicity in hamsters, mice, and rats. Fundam Appl Toxicol 1988, 10:635-647.
11. Piasek M., Laskey J., Kostial K., Blanuša M. Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue. Int Arch Occup Environ Health 2002, 75:36-44.
12. Leoni G., Bogliolo L., Deiana G., Berlinguer F., Rosati I., Pintus P.P., et al. Influence of cadmium exposure on in vitro ovine gamete dysfunction. Reprod Toxicol 2002, 16:371-377.
13. Yu H.S., Tam P.P.L., Chan S.T.H. Effects of cadmium on preimplantation mouse embryos in vitro with special reference to their implantation capacity and subsequent development. Teratology 1985, 32:347-353.
14. Nishijo M., Nakagawa H., Honda R., Tanebe K., Saito S., Teranishi H., et al. Effects of maternal exposure to cadmium on pregnancy outcome and breast milk. Occup Environ Med 2002, 59:394-396. discussion 7.
15. Akesson A., Julin B., Wolk A. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res 2008, 68:6435-6441.
16. Rogers P.A.W., Donoghue J.F., Walter L.M., Girling J.E. Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci 2009, 16:147-151.
17. Demir R., Yaba A., Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem 2010, 3:203-214.
18. Gargett C.E., Rogers P.A. Human endometrial angiogenesis. Reproduction 2001, 121:181-186.
19. Girling J., Rogers P. Recent advances in endometrial angiogenesis research. Angiogenesis 2005, 8:89-99.
20. Torry D., Leavenworth J., Chang M., Maheshwari V., Groesch K., Ball E., et al. Angiogenesis in implantation. J Assist Reprod Genet 2007, 24:303-315.
21. Nardo L.G. Vascular endothelial growth factor expression in the endometrium during the menstrual cycle, implantation window and early pregnancy. Curr Opin Obstet Gynecol 2005, 17:419-423.
22. Krikun G., Schatz F., Taylor R., Critchley H.O.D., Rogers P.A.W., Huang J., et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrin Metabol 2005, 90:1812-1818.
23. Iruela-Arispe M.L., Rodriguez-Manzaneque J.C., Abu-Jawdeh G. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation 1999, 6:127-140.
24. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., et al. Cadmium induces mitogenic signaling in breast cancer cell by an ER[alpha]-dependent mechanism. Mol Cell Endocrinol 2007, 264:102-108.
25. Zang Y., Odwin-DaCosta S., Yager J.D. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells. Toxicol Lett 2009, 184:134-138.
26. Choe S.-Y., Kim S.-J., Kim H.-G., Lee J.H., Choi Y., Lee H., et al. Evaluation of estrogenicity of major heavy metals. Sci Total Environ 2003, 312:15-21.
27. Tsutsumi R., Hiroi H., Momoeda M., Hosokawa Y., Nakazawa F., Yano T., et al. Induction of early decidualization by cadmium, a major contaminant of cigarette smoke. Fertil Ster 2009, 91:1614-1617.
28. Zhang W., Yang J., Wang J., Xia P., Xu Y., Jia H., et al. Comparative studies on the increase of uterine weight and related mechanisms of cadmium and p-nonylphenol. Toxicology 2007, 241:84-91.
29. Bredhult C., Bäcklin B.-M., Olovsson M. Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod Toxicol 2007, 23:550-559.
30. Bredhult C., Sahlin L., Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to op'-DDT. Mol Hum Reprod 2008, 14:97-106.
31. Bredhult C., Sahlin L., Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to Bisphenol A. Reprod Toxicol 2009, 28:18-25.
32. Shin H.-J., Park K.-K., Lee B.-H., Moon C.-K., Lee M.-O. Identification of genes that are induced after cadmium exposure by suppression subtractive hybridization. Toxicology 2003, 191:121-131.
33. Woods J.M., Leone M., Klosowska K., Lamar P.C., Shaknovsky T.J., Prozialeck W.C. Direct antiangiogenic actions of cadmium on human vascular endothelial cells. Toxicol In Vitro 2008, 22:643-651.
34. Prozialeck W.C., Edwards J.R., Woods J.M. The vascular endothelium as a target of cadmium toxicity. Life Sci 2006, 79:1493-1506.
35. Ramakers C., Ruijter J.M., Deprez R.H.L., Moorman A.F.M. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003, 339:62-66.
36. Ruijter J.M., Ramakers C., Hoogaars W.M., Karlen Y., Bakker O., van den Hoff M.J., et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009, 37:e45.
37. Barbier C., Kloosterboer H.J., Kaufman D.G. Effects of tibolone metabolites on human endometrial cell lines in co-culture. Reprod Sci 2008, 15:75-82.
38. Markus M., Despina M., Monika S., Igor H., Roland K., Jens G. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells. Exp Dermatol 2009, 18:863-869.
39. Autiero M., Luttun A., Tjwa M., Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003, 1:1356-1370.
40. Tammela T., Enholm B., Alitalo K., Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005, 65:550-563.
41. Moller B., Ronnerdag M., Wang G., Odlind V., Olovsson M. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system. Hum Reprod 2005, 20:1410-1417.
42. Klagsbrun M., A.D'Amore P. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996, 7:259-270.
43. Parast C.V., Mroczkowski B., Pinko C., Misialek S., Khambatta G., Appelt K. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis. Biochemistry 1998, 37:16788-16801.
44. Ben-Shoshan J., Maysel-Auslender S., Luboshits G., Barshack I., Polak-Charcon S., Tzahor E., et al. Hypoxia-inducible factor-1alpha and -2alpha additively promote endothelial vasculogenic properties. J Vasc Res 2009, 46:299-310.
45. Stoica A., Katzenellenbogen B.S., Martin M.B. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000, 14:545-553.
46. Taupeau C., Poupon Jl., Treton D., Brosse Al, Richard Y., Machelon Vr. Lead reduces messenger RNA and protein levels of cytochrome P450 aromatase and estrogen receptor beta in human ovarian granulosa cells. Biol Reprod 2003, 68:1982-1988.
47. Mouriec K., Lareyre J.J., Tong S.K., Page Y.L., Vaillant C., Pellegrini E., et al. Early regulation of brain aromatase (cyp19a1b) by estrogen receptors during zebrafish development. Dev Dyn 2009, 238:2641-2651.
48. Bongers T.N., de Maat M.P.M., van Goor M-LPJ, Bhagwanbali V., van Vliet H.H.D.M., Gomez Garcia E.B., et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 2006, 37:2672-2677.
49. Prozialeck W.C., Edwards J.R., Nebert D.W., Woods J.M., Barchowsky A., Atchison W.D. The vascular system as a target of metal toxicity. Toxicol Sci 2008, 102:207-218.
50. Kuester R.K., Waalkes M.P., Goering P.L., Fisher B.L., McCuskey R.S., Sipes I.G. Differential hepatotoxicity induced by cadmium in Fischer 344 and Sprague-Dawley rats. Toxicol Sci 2002, 65:151-159.
51. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998, 111:1853-1865.
52. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008, 121:2115-2122.